Synmosa Biopharma Corporation (4114.TWO)
Taipei Exchange · TWD · Healthcare · Drug Manufacturers - Specialty & Generic
NT$28.95 (-0.34%) as of
Key statistics
- Market cap
- 14.77B
- P/E (TTM)
- 18.68
- Forward P/E
- 12.42
- EPS (TTM)
- 1.55
- Dividend yield
- 2.91%
- 52-week range
- 27.55 – 31.67
- Beta
- -0.01
- Revenue (TTM)
- 6.68B
- Profit margin
- 12.38%
- Volume
- 179.90k
About Synmosa Biopharma Corporation
Synmosa Biopharma Corporation, a specialty pharmaceutical company, engages in the manufacturing and sales of various pharmaceuticals and medical devices in Taiwan, China, the United States, Canada, Thailand, Malaysia, Singapore, and internationally. It offers medicines for urology, hormones, oncology, dermatology, cardiovascular, CNS, gastrointestinal, and other areas; and effervescent tables, granules, and nasal sprays. The company is also involved in provision of cosmetics, veterinary drugs, chemical food additives, and beverages; wholesale retail of environmental drugs; and import and export of related businesses. The company was founded in 1959 and is based in Taipei, Taiwan.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Taipei, Taiwan
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.